Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apyx Medical Corporation (DE:BOV)
FRANKFURT:BOV
Apyx Medical (BOV) Stock Price & Analysis
1 Followers
BOV Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.09 - €6.95
Previous Close€1.25
Volume0.00
Average Volume (3M)5.67K
Market Cap
€46.94M
Enterprise Value€41.80M
Total Cash (Recent Filing)$43.70M
Total Debt (Recent Filing)$38.50M
Price to Earnings (P/E)N/A
Beta1.14
Next Earnings
May 09, 2024EPS Estimate
-€0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding34,643,926
10 Day Avg. Volume800
30 Day Avg. Volume5,670
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.82
Price to Sales (P/S)0.86
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.80
Enterprise Value/Gross Profit1.24
Enterprise Value/Ebitda-2.31
Forecast
1Y Price Target
€2.35Price Target Upside87.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Apyx Medical News
PremiumCompany Announcements
Apyx Medical’s Renuvion Technology Featured at AACS Meeting
Bulls Say, Bears Say
Bulls Say
Company GrowthWith a robust pipeline and consistent customer results, Renuvion usage is on the rise, while recent debt financing has bolstered liquidity to support ongoing expansion efforts.
Financial PerformanceAfter a period of lower sales, disposable handpiece revenue has seen a significant rebound, indicating a resurgence in product demand.
Product DifferentiationRenuvion stands out with its unique helium-based plasma technology, showing promise in the expanding plastic surgery sector.
Bears Say
Financial PerformanceThe company's report shows a flat to declining top line for the year ahead, coinciding with a higher net loss.
Market ChallengesSofter cosmetic surgery capital equipment environment domestically is identified as the primary issue affecting sales.
Sales GuidanceInitial 2024 sales guidance came in well below consensus, as management applied a more cautious near-term view.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
3.81% Other Institutional Investors
96.19% Public Companies and
Individual Investors
BOV FAQ
What was Apyx Medical Corporation’s price range in the past 12 months?
Apyx Medical Corporation lowest stock price was €1.09 and its highest was €6.95 in the past 12 months.
What is Apyx Medical Corporation’s market cap?
Currently, no data Available
When is Apyx Medical Corporation’s upcoming earnings report date?
Apyx Medical Corporation’s upcoming earnings report date is May 09, 2024 which is in 4 days.
How were Apyx Medical Corporation’s earnings last quarter?
Apyx Medical Corporation released its earnings results on Mar 21, 2024. The company reported -€0.263 earnings per share for the quarter, missing the consensus estimate of -€0.167 by -€0.096.
Is Apyx Medical Corporation overvalued?
According to Wall Street analysts Apyx Medical Corporation’s price is currently Undervalued.
Does Apyx Medical Corporation pay dividends?
Apyx Medical Corporation does not currently pay dividends.
What is Apyx Medical Corporation’s EPS estimate?
Apyx Medical Corporation’s EPS estimate is -€0.2.
How many shares outstanding does Apyx Medical Corporation have?
Currently, no data Available
What happened to Apyx Medical Corporation’s price movement after its last earnings report?
Apyx Medical Corporation reported an EPS of -€0.263 in its last earnings report, missing expectations of -€0.167. Following the earnings report the stock price went down -19.753%.
Which hedge fund is a major shareholder of Apyx Medical Corporation?
Among the largest hedge funds holding Apyx Medical Corporation’s share is Royce & Associates LLC. It holds Apyx Medical Corporation’s shares valued at 6M.
---
Apyx Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€2.35 (87.61% Upside)
€2.35 (87.61% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.94%
12-Months-Change
Fundamentals
Return on Equity
-58.22%
Trailing 12-Months
Asset Growth
53.05%
Trailing 12-Months
Company Description
Apyx Medical Corporation
Apyx Medical Corp. operates as an energy-based medical technology company. It engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
---
BOV Earnings Call
Q4 2024
0:00 / 0:00
---
BOV Stock 12 Months Forecast
Average Price Target
€2.35
▲(87.61% Upside)
Technical Analysis
Best Analysts Covering BOV
1 Year
1 Year Success Rate
5/15 ratings generated profit
1 Year Average Return
-8.35%
reiterated a buy rating 9 months ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -8.35% per trade.
---